NexVeris AIUpcoming Biotech Catalysts
Track upcoming FDA decisions, PDUFA dates, advisory committees and other material biotech catalysts.
Data snapshot: 2026-10-14T11:47:58.610Z
| Ticker | Company | Drug / event | Date | Source |
|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | PDUFA target action date | 2026-10-17 | Event source |
| VTRS | Viatris Inc. | PDUFA target action date | 2026-10-17 | Event source |
| IONS | IONIS PHARMACEUTICALS, INC. | PDUFA target action date | 2026-10-26 | Event source |
| INO | INOVIO PHARMACEUTICALS, INC. | PDUFA target action date | 2026-10-30 | Event source |
| AGIO | Agios Pharmaceuticals, Inc. | PDUFA target action date | 2026-11-01 | Event source |
| BTAI | BioXcel Therapeutics, Inc. | PDUFA target action date | 2026-11-14 | Event source |
| CYTK | CYTOKINETICS INC | PDUFA target action date | 2026-11-14 | Event source |
| SMMT | Summit Therapeutics Inc. | PDUFA target action date | 2026-11-14 | Event source |
Why company exposure matters
A drug decision may be central to a company with one lead programme and less significant to a diversified manufacturer. Review the drug, indication and business exposure together, not only the calendar date.
What needs checking next?
Confirm the application and target date in the source record. A dated catalyst is a research checkpoint, not a prediction of approval or price direction. Missing fields remain disclosed.